Irene Galani
Irene Galani
Laboratory Teaching Staff, National and Kapodistrian University of Athens, Faculty of Medicine
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα
Παρατίθεται από
Παρατίθεται από
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe
M Souli, I Galani, H Giamarellou
Eurosurveillance 13 (47), 19045, 2008
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
V Miriagou, G Cornaglia, M Edelstein, I Galani, CG Giske, M Gniadkowski, ...
Clinical microbiology and infection 16 (2), 112-122, 2010
An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular …
M Souli, I Galani, A Antoniadou, E Papadomichelakis, G Poulakou, ...
Clinical infectious diseases 50 (3), 364-373, 2010
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
A Antoniadou, F Kontopidou, G Poulakou, E Koratzanis, I Galani, ...
Journal of Antimicrobial Chemotherapy 59 (4), 786-790, 2007
Evaluation of different laboratory tests for the detection of metallo-β-lactamase production in Enterobacteriaceae
I Galani, PD Rekatsina, D Hatzaki, D Plachouras, M Souli, H Giamarellou
Journal of antimicrobial chemotherapy 61 (3), 548-553, 2008
Colistin susceptibility testing by Etest and disk diffusion methods
I Galani, F Kontopidou, M Souli, PD Rekatsina, E Koratzanis, J Deliolanis, ...
International journal of antimicrobial agents 31 (5), 434-439, 2008
Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital
M Souli, FV Kontopidou, E Papadomichelakis, I Galani, A Armaganidis, ...
Clinical infectious diseases 46 (6), 847-854, 2008
In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development
M Souli, I Galani, S Boukovalas, MG Gourgoulis, Z Chryssouli, ...
Antimicrobial agents and chemotherapy 55 (5), 2395-2397, 2011
Colonization and infection by colistin‐resistant Gram‐negative bacteria in a cohort of critically ill patients
F Kontopidou, D Plachouras, E Papadomichelakis, G Koukos, I Galani, ...
Clinical Microbiology and Infection 17 (11), E9-E11, 2011
Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece
I Galani, M Souli, GL Daikos, Z Chrysouli, G Poulakou, M Psichogiou, ...
Journal of Chemotherapy 24 (4), 191-194, 2012
In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa
EJ Giamarellos-Bourboulis, H Sambatakou, I Galani, H Giamarellou
Journal of chemotherapy 15 (3), 235-238, 2003
Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci
V Sakka, S Tsiodras, L Galani, A Antoniadou, M Souli, I Galani, ...
Clinical Microbiology and Infection 14 (1), 14-21, 2008
Characterization of a new integron containing blaVIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece
I Galani, M Souli, Z Chryssouli, K Orlandou, H Giamarellou
Journal of Antimicrobial Chemotherapy 55 (5), 634-638, 2005
Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-β-lactamase-producing Klebsiella pneumoniae isolates?
M Souli, PD Rekatsina, Z Chryssouli, I Galani, H Giamarellou, ...
Antimicrobial agents and chemotherapy 53 (5), 2133-2135, 2009
Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures
T Panagea, I Galani, M Souli, P Adamou, A Antoniadou, H Giamarellou
International journal of antimicrobial agents 37 (2), 124-128, 2011
First identification of an Escherichia coli clinical isolate producing both metalloβ-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1
I Galani, M Souli, Z Chryssouli, D Katsala, H Giamarellou
Clinical microbiology and infection 10 (8), 757-760, 2004
In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth
A Pistiki, I Galani, E Pyleris, C Barbatzas, M Pimentel, ...
International journal of antimicrobial agents 43 (3), 236-241, 2014
Colistin: still a lifesaver for the 21st century?
I Karaiskos, M Souli, I Galani, H Giamarellou
Expert opinion on drug metabolism & toxicology 13 (1), 59-71, 2017
Growth requirements and the establishment of a chemically defined minimal medium inZymomonasmobilis
I Galani, C Drainas, NA Typas
Biotechnology letters 7 (9), 673-678, 1985
Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii
I Galani, K Orlandou, H Moraitou, G Petrikkos, M Souli
International journal of antimicrobial agents 43 (4), 370-374, 2014
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20